Could a nasal spray boost sleep and brain health in seniors?

NCT ID NCT07610343

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a nasal spray containing two medicines, dexmedetomidine and esketamine, can improve sleep quality and thinking abilities in older adults with mild-to-moderate Alzheimer's-related cognitive impairment and sleep problems. Sixty participants will receive either the active spray or a placebo twice a week for four weeks. The main goal is to see if sleep quality gets better, with a secondary look at whether thinking skills also improve.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexmedetomidine and esketamine nasal spray
What this could lead to
If it works, this could point toward a new way to improve sleep and possibly slow cognitive decline in older adults with Alzheimer's disease.
What could go wrong
This is a small, early-phase trial with only 60 participants. The combination may cause side effects like low blood pressure, slow heart rate, or neuropsychiatric issues, and it may not improve sleep or cognition as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.